NCT03466034View on ClinicalTrials.gov

The Role of Hypoxia as a Selective Pressure for TP53 Mutations

TerminatedOBSERVATIONAL

Enrollment

5

Participants

Timeline

Start Date

February 6, 2018

Primary Completion Date

June 19, 2018

Study Completion Date

July 30, 2019

Conditions

Endometrial Cancer

Trial Locations (1)

SM2 5PT

The Institute of Cancer Research & The Royal Marsden NHS Foundation Trust, Sutton

Sponsors

Collaborators (1)

Cancer Research UK

All Listed Sponsors

collaborator

Cancer Research UK

OTHER

lead

Institute of Cancer Research, United Kingdom

OTHER